Medtronic | GenomeWeb

Medtronic

After a five-year pilot, only one company has successfully taken a test through parallel review, but there is growing industry interest.

Gathering the Data

IBM and its partners look to combine health information to develop a health platform for the Watson supercomputer.

Title: Methods for Diagnosing Prostate Cancer using microRNAs
Patent Number: 8,557,520
Filed: Feb. 28, 2012
Lead Inventor: Carlo Croce, Ohio State University

NEW YORK (GenomeWeb News) – In a sort of test case for personalized medicine, a team of clinicians and researchers used whole-genome sequencing to uncover variants possibly linked to a patient's obsessive-compulsive disorder.

Response Genetics, Taiho Extend MDx Services Pact
Response Genetics could receive up to $950,000 for molecular diagnostic testing services provided to Taiho Pharmaceutical related to the development of cancer treatments.

Dutch gene therapy firm UniQure and academic collaborators have been awarded a three-year grant worth €2.5 million ($3.2 million) from the European Commission to develop a treatment for Huntington’s disease that combines RNAi and gene replacement.

Title: Expression System
Patent Number: 8,415,148
Filed: Aug. 2, 2011
Inventor: Jacques Perrault, San Diego State University

Title: Method for Diagnosing Acute Lymphomic Leukemia using miR-222
Patent Number: 8,349,560
Filed: Oct. 17, 2011
Inventor: Carlo Croce, Ohio State University

Title: miRNA Triplex Formations for the Down-Regulation of Viral Replication
Patent Number: 8,323,891
Filed: July 30, 2009
Inventor: Omar Bagasra, Claflin University

Title: shRNA Molecules and Methods of Use
Patent Number: 8,252,526
Filed: Nov. 9, 2007
Lead Inventor: Donald Rao, Gradalis

Pages

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.